This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Lg Life Sciences, Limited. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Hwa-Dong Kim: Innovator in Caspase Inhibition
Introduction
Hwa-Dong Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic agents. His work focuses on innovative solutions for preventing inflammation and apoptosis.
Latest Patents
Hwa-Dong Kim holds a patent for "Caspase inhibitors containing isoxazoline ring." This invention relates to an isoxazoline derivative that acts as an inhibitor against various caspases. The patent also details a process for preparing the isoxazoline derivative and a therapeutic composition that utilizes it for preventing inflammation and apoptosis. He has 1 patent to his name.
Career Highlights
Hwa-Dong Kim is currently employed at LG Life Sciences, Limited, where he continues to advance his research and development efforts. His work has the potential to impact various therapeutic applications, particularly in the treatment of diseases associated with inflammation.
Collaborations
Some of his notable coworkers include Hye-Kyung Chang and Yeong-Soo Oh, who contribute to the collaborative efforts in their research projects.
Conclusion
Hwa-Dong Kim's innovative work in caspase inhibition showcases his dedication to advancing medical science. His contributions are vital for developing new therapeutic strategies to combat inflammation and apoptosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile